Skip to main content
John Stafford, MD, Endocrinology, Nashville, TN

JohnMichaelStaffordMDPhD

Endocrinology Nashville, TN

Diabetes, Lipid Metabolism

Associate Professor of Medicine, Division of Diabetes, Endocrinology and Metabolism Vanderbilt University School of Medicine / Section Chief of Endocrinology and Director of the Lipid Clinic, Tennessee Valley Veterans Hospital

Dr. Stafford is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Stafford's full profile

Already have an account?

  • Office

    7435 21st Ave S
    Nashville, TN 37232
    Phone+1 615-936-6113

Summary

  • John M. Stafford, MD., PhD is a physician-scientist at Vanderbilt University medical center whose research focuses on the mechanisms by which obesity and diabetes contribute to risk of non alcoholic fatty liver disease (NAFLD) and cardiovascular disease. Dr. Stafford is an Associate Professor of Medicine, in the Division of Diabetes, Endocrinology and Metabolism, and Molecular Physiology and Biophysics. He is also an investigator and clinician at the Veterans Administration Tennessee Valley Healthcare System. Dr. Stafford completed his MD, PhD training at Vanderbilt University Medical Center, where his graduate studies defined how metabolic signals are coordinated at the level of gene transcription. His medical residency, and fellowship in Endocrinology were also performed at Vanderbilt. Since his appointment to the Vanderbilt faculty in 2008, Dr. Stafford directs an active research program in obesity and lipid metabolism funded by the American Diabetes Association, American Heart Association, The National Institutes of Health, Department of Veterans Affairs, and the John A. Hartford Foundation. This work has revealed important hepatic pathways that lessen the impact of obesity on glucose metabolism and HDL function.

Education & Training

  • Vanderbilt University Medical Center
    Vanderbilt University Medical CenterFellowship, Endocrinology, Diabetes, and Metabolism, 2005 - 2008
  • Vanderbilt University Medical Center
    Vanderbilt University Medical CenterResidency, Internal Medicine, 2003 - 2005
  • Vanderbilt University School of Medicine
    Vanderbilt University School of MedicineClass of 2003

Certifications & Licensure

  • TN State Medical License
    TN State Medical License 2005 - 2026
  • American Board of Internal Medicine Endocrinology, Diabetes and Metabolism

Publications & Presentations

PubMed

Journal Articles

  • CETP Inhibition Improves HDL Function but Leads to Fatty Liver and Insulin Resistance in CETP-Expressing Transgenic Mice on a High-Fat Diet  
    Lin Zhu, Thao Luu, Christopher H. Emfinger, Bryan A Parks, Jeanne Shi, Elijah Trefts, Fenghua Zeng, Zsuzsanna Kuklenyik, Raymond C. Harris, David H. Wasserman, Sergio ..., Diabetes, 9/2018

Grant Support

  • CETP and Sex-Differences in Metabolic and Cardiovascular DiseaseNIH-NHLBI2019–2024
  • Estrogen and coordinated metabolism of carbohydrate and lipids with obesityNIH/NIDDKPresent

Professional Memberships